Journal article
bioRxiv, 2021
Systematic discovery of protein functions in human cells to understand gene regulation and enable gene therapy
Systematic discovery of protein functions in human cells to understand gene regulation and enable gene therapy
Department of Neurobiology
Harvard Medical School
APA
Click to copy
Marinov, G., Kim, S. H., Bagdatli, S., Trevino, A. E., Tycko, J., Wu, T., … Greenleaf, W. (2021). Direct profiling of genome-wide dCas9 and Cas9 specificity using ssDNA mapping (CasKAS). BioRxiv.
Chicago/Turabian
Click to copy
Marinov, G., Samuel H. Kim, S. Bagdatli, Alexandro E. Trevino, Josh Tycko, Tong Wu, Lacramioara Bintu, et al. “Direct Profiling of Genome-Wide dCas9 and Cas9 Specificity Using SsDNA Mapping (CasKAS).” bioRxiv (2021).
MLA
Click to copy
Marinov, G., et al. “Direct Profiling of Genome-Wide dCas9 and Cas9 Specificity Using SsDNA Mapping (CasKAS).” BioRxiv, 2021.
BibTeX Click to copy
@article{g2021a,
title = {Direct profiling of genome-wide dCas9 and Cas9 specificity using ssDNA mapping (CasKAS)},
year = {2021},
journal = {bioRxiv},
author = {Marinov, G. and Kim, Samuel H. and Bagdatli, S. and Trevino, Alexandro E. and Tycko, Josh and Wu, Tong and Bintu, Lacramioara and Bassik, M. and He, Chuan and Kundaje, A. and Greenleaf, W.}
}
Detecting and mitigating off-target activity is critical to the practical application of CRISPR-mediated genome and epigenome editing. While numerous methods have been developed to map Cas9 binding specificity genome-wide, they are generally time-consuming and/or expensive, and not applicable to catalytically dead CRISPR enzymes. We have developed a rapid, inexpensive, and facile assay for identifying off-target CRISPR enzyme binding and cleavage by chemically mapping the unwound single-stranded DNA structures formed upon binding of a sgRNA-loaded Cas9 protein (“CasKAS”). We demonstrate this method in both in vitro and in vivo contexts.